Chemiluminescence Immunoassay Analyzers Global Market Outlook 2017-2026
Chemiluminescence Immunoassay Analyzers Market, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years.
(EMAILWIRE.COM, October 05, 2018 ) The global chemiluminescence immunoassay (CLIA) analyzers market is witnessing continuous innovations in test offerings and wide product portfolio of major as well as local manufacturers. The collaborations among major market players for superior technological advancements in test offerings is likely to drive the growth of global chemiluminescence immunoassay (CLIA) analyzers market during the forecast period. The CLIA technology provides enhanced sensitivity, specificity, improved precision, and reduced incubation, which together increases efficiency of this technique. The method also provides precise results with lower variation and improved comparability with the standards used in the assays. Major manufacturers operating in the market are involved in continuous research & development activities to expand their already wide product portfolio.
Top key players in global Chemiluminescence Immunoassay Analyzers market are -
Chemiluminescence immunoassay market include Siemens AG Healthcare, BioMérieux, Abbott Laboratories, Johnson & Johnson, Tosoh Corporation, Randox Laboratories Ltd, Ortho Clinical Diagnostics, Sysmex Corporation, DiaSorin S.p.A., Beckman Coulter, Danaher, F. Hoffmann-La Roche Ltd and Shenzhen New Industries Biomedical Engineering Co., Ltd.
Request sample copy at: https://www.reportsweb.com/inquiry&RW00012094890/sample
Global Chemiluminescence Immunoassay market is accounted for $4.53 billion in 2017 and is expected to reach $8.38 billion by 2026 growing at a CAGR of 7.1%. Increasing adoption of advanced technologies, rising incidences of chronic diseases demanding affordable care & advanced compassion and accuracy of Chemiluminescence immunoassay over enzyme are the factors driving the market growth. However, fragmented consumables market affecting profit margin negatively impacts the market growth. In addition, development of integrated analyzers with multiple components and multiplexing modalities with high-throughput provides ample opportunities for the market growth.
Chemiluminescence immunoassay (CLIA) is an immunoassay technique where the label, i.e. the true "indicator" of the analytic reaction, is a luminescent molecule. CLIA instruments progressively infiltrated the immunometric assay domain, eventually being used to measure serum concentrations of hormones, drugs, vitamins, tumour markers, infectious disease markers, myocardial damage markers and, finally, autoantibodies. Today, autoantibody detection in immunochemiluminescence can be carried out on instruments specifically dedicated to the autoimmunology laboratory as stand-alone instrumentation or as part of an automated analytical platform.
Amongst Product, reagents segment held considerable market share during the predicted period due to relative higher frequency of reagent substitute when compared to analyzer systems. By geography, North America dominated the market during the forecast period due to the high acceptance of sophisticated technologies, large base of diagnostic laboratories and growth of pharmaceutical.
Have any query? Enquire about report at: https://www.reportsweb.com/inquiry&RW00012094890/buying
Types Covered:
- Low Throughput
- Medium Throughput
- High Throughput
Products Covered:
- Reagents
- Consumables
- Analyzers
Applications Covered:
- Toxicology Screening
- Endocrine disorders
- Bone and Mineral Disorders
- Cardiovascular Disorders
- Auto-immune Diseases
- Blood Disorders
- Oncology
- Allergy
- Drug Discovery and Development
- Infectious Diseases
- Hepatitis & Retrovirus
- Other Applications
End Users Covered:
- Contract Research Organization
- Hospitals
- Pharmaceuticals
- Medical & Diagnostic Laboratories
Get more information at: https://www.reportsweb.com/inquiry&RW00012094890/buying
Top key players in global Chemiluminescence Immunoassay Analyzers market are -
Chemiluminescence immunoassay market include Siemens AG Healthcare, BioMérieux, Abbott Laboratories, Johnson & Johnson, Tosoh Corporation, Randox Laboratories Ltd, Ortho Clinical Diagnostics, Sysmex Corporation, DiaSorin S.p.A., Beckman Coulter, Danaher, F. Hoffmann-La Roche Ltd and Shenzhen New Industries Biomedical Engineering Co., Ltd.
Request sample copy at: https://www.reportsweb.com/inquiry&RW00012094890/sample
Global Chemiluminescence Immunoassay market is accounted for $4.53 billion in 2017 and is expected to reach $8.38 billion by 2026 growing at a CAGR of 7.1%. Increasing adoption of advanced technologies, rising incidences of chronic diseases demanding affordable care & advanced compassion and accuracy of Chemiluminescence immunoassay over enzyme are the factors driving the market growth. However, fragmented consumables market affecting profit margin negatively impacts the market growth. In addition, development of integrated analyzers with multiple components and multiplexing modalities with high-throughput provides ample opportunities for the market growth.
Chemiluminescence immunoassay (CLIA) is an immunoassay technique where the label, i.e. the true "indicator" of the analytic reaction, is a luminescent molecule. CLIA instruments progressively infiltrated the immunometric assay domain, eventually being used to measure serum concentrations of hormones, drugs, vitamins, tumour markers, infectious disease markers, myocardial damage markers and, finally, autoantibodies. Today, autoantibody detection in immunochemiluminescence can be carried out on instruments specifically dedicated to the autoimmunology laboratory as stand-alone instrumentation or as part of an automated analytical platform.
Amongst Product, reagents segment held considerable market share during the predicted period due to relative higher frequency of reagent substitute when compared to analyzer systems. By geography, North America dominated the market during the forecast period due to the high acceptance of sophisticated technologies, large base of diagnostic laboratories and growth of pharmaceutical.
Have any query? Enquire about report at: https://www.reportsweb.com/inquiry&RW00012094890/buying
Types Covered:
- Low Throughput
- Medium Throughput
- High Throughput
Products Covered:
- Reagents
- Consumables
- Analyzers
Applications Covered:
- Toxicology Screening
- Endocrine disorders
- Bone and Mineral Disorders
- Cardiovascular Disorders
- Auto-immune Diseases
- Blood Disorders
- Oncology
- Allergy
- Drug Discovery and Development
- Infectious Diseases
- Hepatitis & Retrovirus
- Other Applications
End Users Covered:
- Contract Research Organization
- Hospitals
- Pharmaceuticals
- Medical & Diagnostic Laboratories
Get more information at: https://www.reportsweb.com/inquiry&RW00012094890/buying
Contact Information:
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results